BARBARA HOLDSWORTH: Open Payments
NPI 1477747186 · VENTURA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,847 in 79 payments from 24 companies in 2025. Trend: 2023 $3,695 · 2024 $3,965 · 2025 $1,847
Food & beverage: $1,747Education: $100
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 16 | $247 |
| AstraZeneca Pharmaceuticals LP | 2 | $190 |
| Dexcom, Inc. | 4 | $152 |
| Astellas Pharma US Inc | 5 | $150 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 7 | $142 |
| Lilly USA, LLC | 7 | $107 |
| Amphastar Pharmaceuticals, Inc. | 4 | $95 |
| Amgen Inc. | 4 | $84 |
| Almatica Pharma LLC | 4 | $68 |
| SANOFI-AVENTIS U.S. LLC | 2 | $66 |
Products named: JARDIANCE, Ozempic, Dexcom G6 Transmitter, LOKELMA, TZIELD, FARXIGA, Yorvipath, AFREZZA.
Industry payments across CA — which companies pay providers there.
